Highlight text to provide feedback
| Disease found: | Acromegaly |
| Current as of: | October 8, 2024 |
| Disease Overview: | Disorder characterized by excessive growth hormone (GH) production [more info] |
| Signs and Symptoms: | Wide variety of symptoms and physical findings; characterisitic facial prominence, gradual enlargement of hands and feet [more info]. |
| Diagnosis: | Detailed patient history, a thorough clinical evaluation, identification of characteristic findings; elevated levels of growth hormone or IGF-1 (insulin growth factor) [more info]. |
| Treatment: | Transsphenoidal surgery for pituitary removal [more info] |
| Clinical Management: | Ocretoride (somatostatin analog), bromocriptine and cabergoline (dopamine agonist), pegvisomat (GH antagonist) [more info] |
| Referral: | ~ 3000 physicians [more info]. Referral to Medical Genetics Department, if available. Initial virtual care is also available through organizations like TeleRare Health. |
| Clinical Trials: | 13 actively recruiting [more info] |